Vanderbilt-Ingram Cancer Center has launched the nation's first personalized cancer decision support tool, "My Cancer Genome," to help physicians and researchers track the latest developments in personalized cancer medicine and connect with clinical research trials for their patients, according to a hospital news release.
Instead of having to search through a medical literature, the physician can log on to VICC's My Cancer Genome tool, which is designed to quickly educate clinicians on the rapidly expanding list of genetic mutations that impact different cancers and enable them to more easily research various treatment options based on specific mutations. Patients also can go to the VICC website and learn more about their cancer by using the My Cancer Genome tool.
The first two forms of cancer featured on VICC's My Cancer Genome information tool are lung cancer and melanoma, with plans to add content on breast, colon and other cancers in a few months.
Read the news release about VICC's My Cancer Genome tool.
Read other coverage about clinical decision support:
- NLM's Drug-Naming Standard May Improve Clinical Decision Support
- Study Suggests Clinical Decision Support Can Prevent Unnecessary Imaging
- ONC to Establish "Communities of Practice" for Clinical Decision Support Technology
Instead of having to search through a medical literature, the physician can log on to VICC's My Cancer Genome tool, which is designed to quickly educate clinicians on the rapidly expanding list of genetic mutations that impact different cancers and enable them to more easily research various treatment options based on specific mutations. Patients also can go to the VICC website and learn more about their cancer by using the My Cancer Genome tool.
The first two forms of cancer featured on VICC's My Cancer Genome information tool are lung cancer and melanoma, with plans to add content on breast, colon and other cancers in a few months.
Read the news release about VICC's My Cancer Genome tool.
Read other coverage about clinical decision support:
- NLM's Drug-Naming Standard May Improve Clinical Decision Support
- Study Suggests Clinical Decision Support Can Prevent Unnecessary Imaging
- ONC to Establish "Communities of Practice" for Clinical Decision Support Technology